Should you buy Qiagen NV (QGEN) in the diagnostics and research industry?

A rating of 82 places Qiagen NV (QGEN) near the top of the diagnostics and research industry according to InvestorsObserver. Qiagen NV’s score of 82 means it scores above 82% of industry stocks. Qiagen NV also received an overall rating of 53, which puts it above 53% of all shares. Diagnostics & Research is ranked 112th out of 148 industries.

QGEN has an overall score of 53. Find out what this means for you and get the rest of the rankings on QGEN!

What do these notes mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks to determine which ones perform best. InvestorsObserver makes the whole process easier by using percentile rankings that make it easy for you to find the stocks that have the strongest analyst valuations. These rankings allow you to easily compare stocks and see what the strengths and weaknesses of a given company are. This allows you to find the stocks with the best short-term and long-term growth prospects in seconds. The combined score incorporates technical and fundamental analysis to provide a comprehensive view of a stock’s performance. Investors who then want to focus on analyst rankings or valuations can see separate scores for each section.

What is happening with Qiagen NV shares today?

Qiagen NV (QGEN) stock is trading at $46.20 at 11:13 a.m. on Friday, March 4, down -$2.13, or -4.41% from the previous closing price of 48, $33. The stock has traded between $46.14 and $46.81 so far today. Today, the volume is below average. So far, 361,184 shares have been traded with an average volume of 690,285 shares. Click here for the full report on Qiagen NV shares.

Stay in the know

Subscribe to our daily morning update newsletter and never miss market news, moves and more.

Thank you for signing up! You are ready to receive the Morning Update newsletter

Comments are closed.